Uploaded November 2026 | Updated November 2026, 3 hours ago
🎙️ A new treatment option for adults living with recurrent respiratory papillomatosis.
The FDA has granted accelerated approval to Voceryq to reduce the need for repeated surgeries in patients with RRP.
What does this development mean for the rare disease community?
Watch this week’s The CheckRare Brief for the latest news checkrare.com/3d-printed-treatment-options-the-checkrare-brief
#RareDiseaseNews #RRP #CheckRare
🎙️ A new treatment option for adults living with recurrent respiratory papillomatosis.
The FDA has granted accelerated approval to Voceryq to reduce the need for repeated surgeries in patients with RRP.
What does this development mean for the rare disease community?
Watch this week’s The CheckRare Brief for the latest news checkrare.com/3d-printed-treatment-options-the-checkrare-brief
#RareDiseaseNews #RRP #CheckRare










